Top Stories

Elanco Receives FDA Approval for Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets), the Broadest(i) Canine Oral Parasiticide Protection in a Single Monthly Dose

Elanco Receives FDA Approval for Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets), the Broadest(i) Canine Oral Parasiticide Protection in a Single Monthly Dose

Source: PR Newswire Elanco Animal Health has announced FDA approval for Credelio Quattro™, a new monthly chewable tablet offering the broadest parasite protection for dogs. Credelio Quattro protects against six types of parasites: fleas, ticks, heartworms, and three...

read more
Pet Startup Funding Has Slowed

Pet Startup Funding Has Slowed

Source: Crunchbase News  The global pet care industry is booming, with spending surpassing $320 billion in 2023 and projected to reach nearly $500 billion by 2030. Despite this growth, investment in pet care startups has slowed, with just over $500 million invested...

read more

Contributors